Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013

Your body is 3D, why is your cell culture not?

27 Sep 2013 - 27 Sep 2013 - Webinar

Bookmark and Share

3D cell-based applications close the gap between conventional in-vitro approaches and in vivo animal model research. By automating the 3D cell culture process and assay detection in a microplate based format, this significantly shortens development time of new drug candidates as well as offering more reliable statistical results.   

Tecan will present solutions for 3D cell culture systems using the Alvetex (Reinnervate), RAFT (TAP Biosystems)  scaffold based, and GravityPlus (InSphero) scaffold-free technology. In particular, automating a 3D cell culture system with the Freedom EVO® liquid handling platform offers a simple and reliable approach for cultivation, and the Infinite M-200 PRO multi-detection reader with its Optimal Read function in conjunction with the patent pending Gas Control Module (GCMTM) offers an excellent solution for acute and chronic toxicity tests, as well as multiplexed assays in cancer research.

Christian Oberdanner, PhD
Application Specialist Sales & Marketing, Tecan Austria GmbH

Christian Oberdanner, PhD, studied Molecular- and Cell-Biology at the University of Salzburg, Austria. In his doctoral thesis he focused on Reactive Oxygen Species-mediated apoptosis induction in photodynamic cancer therapy. 

Christian started to work for Tecan Austria as an external scientific consultant already during his last year at University. After his graduation he joined Tecan as Application Specialist in the department for research and development but quickly changed to the sales and marketing department. His expertise is on applications for Tecan’s multimode readers and microplate washers but he is also contributing to new product developments as a Junior Product Manager.

Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos